These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16483045)

  • 1. Serum lipid profile of Nigerian diabetics with end stage renal disease.
    Agaba EI; Duguru M; Agaba PA; Angbazo D
    West Afr J Med; 2005; 24(4):305-8. PubMed ID: 16483045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidaemia among Nigerian oil workers with type 2 diabetes mellitus.
    Edo A; Adediran OS
    West Afr J Med; 2011; 30(3):206-9. PubMed ID: 22120488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are lipoprotein disturbances in chronic hemodialyzed patients only renal failure related?
    Jakić M; Lovcić V; Klarić D; Mihaljević D; Zibar L; Jakić M; Marić I
    Coll Antropol; 2010 Mar; 34 Suppl 1():181-8. PubMed ID: 20402316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
    Khan SR; Ayub N; Nawab S; Shamsi TS
    J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of total cholesterol and high density lipoprotein--cholesterol ratio in interpreting lipid profile results of diabetes mellitus patients.
    Mshelia DS; Garbati MA; Ndahi AA; Mamza YP; Sheikh HA
    Niger J Clin Pract; 2009 Dec; 12(4):345-9. PubMed ID: 20329668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease.
    Ogunro PS; Balogun WO; Fadero FF; Idogun ES; Oninla SO; Elemile PO; Eziyi AK
    West Afr J Med; 2009 Mar; 28(2):87-91. PubMed ID: 19761169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Metabolism in Patients with End-Stage Renal Disease: A Five Year Follow-up Study.
    Dusejovska M; Stankova B; Vecka M; Rychlíkova J; Mokrejsova M; Rychlík I; Zak A
    Curr Vasc Pharmacol; 2018; 16(3):298-305. PubMed ID: 28554308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small dense LDL particle/large buoyant LDL particle ratio is associated with glucose metabolic status in pregnancy.
    Chen Y; Du M; Xu J; Chen D
    Lipids Health Dis; 2017 Dec; 16(1):244. PubMed ID: 29241449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of type 2 diabetics presenting with end stage renal disease at the Jos University Teaching Hospital, Nigeria.
    Agaba EI
    West Afr J Med; 2004; 23(2):142-5. PubMed ID: 15287294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipid and lipoprotein levels of middle-aged and elderly Chinese men and women in Shandong Province.
    Wang M; Hou X; Hu W; Chen L; Chen S
    Lipids Health Dis; 2019 Mar; 18(1):58. PubMed ID: 30832658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of Non-Fasting Lipid Profile for the Assessment of Lipoprotein Coronary Risk.
    Fatima S; Ijaz A; Sharif TB; Khan DA; Siddique A
    J Coll Physicians Surg Pak; 2016 Dec; 26(12):954-957. PubMed ID: 28043305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.